Brief: MyMD Pharmaceuticals Announces Issuance Of U.S. Patent For Use Of Lead Candidate Mymd-1 For Treating Fibrosis And Asthma

Q/C Technologies

24/08/2021 15:24

Aug 24 (Reuters) - MyMD Pharmaceuticals Inc  MYMD.O :
    * MYMD PHARMACEUTICALS ANNOUNCES ISSUANCE OF U.S. PATENT FOR
USE
OF LEAD CANDIDATE MYMD-1 FOR TREATING FIBROSIS AND ASTHMA

Source text for Eikon:  urn:newsml:reuters.com:*:nBw8LS4b3a
Further company coverage:  MYMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))